Skip to content
MedTech Post-Market Compliance

Handle every complaint, from first email to MHRA report

Complaint intake, report preparation, corrective actions and trend review in one case record.

UK MDR Part 4A, in force since 16 June 2025 Devices, IVDs and active implantables GB, NI and EU rules on one case
Post-market surveillance hub on DeX
Audit trail on Example data
Case inbox
See everything open
CaseDeviceSeverityClockOwnerStatus
PMS-0418Occlusion alarm not triggeredInfusion pump IP-200Lot 24-117High01d 06hJPJ. PatelReport drafting
PMS-0421Display flicker reported by distributorPatient monitor PM-5Lot 25-031MediumNot startedAKA. KhanTriage
PMS-0415Unexpected result, repeat test differsIVD analyser QX-1Reagent lot R-882High04d 19hSRS. ReidInvestigating
PMS-0422Packaging seal complaint, portalInfusion set IS-12Lot 25-204LowNot startedAIAgentIntake
PMS-0409Service record: battery faultPatient monitor PM-5Lot 24-990Medium09d 02hJPJ. PatelFollow-up

Select a case to open its record. Devices, lots, people and timers are illustrative.

Source message · distributor email

Customer site reports the IP-200 pump did not raise an occlusion alarm during infusion. Line was found kinked by nursing staff. Patient monitored, no injury. Unit serial 7741-A from lot 24-117 is quarantined for return.

Extracted fields

DeviceInfusion pump IP-200
Model / lotIP-200 · 24-117
EventAlarm failure, occlusion
Patient outcomeNo injury reported

Timeline

  1. Email received and case created09:12
  2. Device, model and lot matched09:13
  3. Duplicate check: 1 linked case09:13
  4. Reportability proposal awaiting sign-off09:20

Linked cases

PMS-0392 · Same lot, alarm delayClosed
AI proposal · PMS-0418Awaiting sign-off
Proposed: reportable serious incident

Alarm failure on a device whose alarm is a risk control. A recurrence could lead to serious deterioration in health. Criteria from the manufacturer's PMS procedure are cited below.

Review pending. Reporting deadlines run from manufacturer awareness, not reviewer confirmation.

Criteria checklist

  • An incident occurred involving the device
  • The device is suspected to be a contributory cause
  • ?Outcome could have led to serious deterioration in health
  • Similar event found in linked case PMS-0392

The lead confirms or overrides. Each decision is stored with its rationale.

MHRA vigilance report · PMS-0418Pre-filled 86%
Manufacturer and device detailsComplete
Event description and outcomeComplete
Distribution of affected lotMissing field
Initial root cause assessmentNeeds input
Review and approvePending

Missing-field prompt

Agent: Units shipped from lot 24-117 by market are needed. Request sent to Supply Chain; reminder set before the clock threshold.

Submission log

draft v1 generated 09:41
RA review requested · J. Patel
● awaiting approval
  follow-up report scheduled

Open 2

CAPA-071 · Alarm threshold review
SRS. ReidDue 28 Oct
CAPA-073 · Seal supplier audit
AKA. KhanDue 04 Nov

Investigate 1

CAPA-069 · Lot 24-117 root cause
FSCA linkedDue 21 Oct

Implement 1

CAPA-064 · Firmware alarm fix
JPJ. PatelDue 30 Oct

Effectiveness check 1

CAPA-058 · Battery supplier change
EffectiveClosed

Actions by stage, owner, due date and effectiveness check. Customer notifications are tracked with each FSCA.

Complaint rate by lot · Infusion pump IP-200per 1,000 units
Within thresholdAbove thresholdAlert threshold

Open signals

IP-200 lot 24-117 · alarm failuresReview
PM-5 · battery faults, GB marketWatching

Slice by

LotDeviceFailure modeMarket
PMSR · Infusion pump family
1. Device description and scopeApproved
2. Complaint and incident summaryApproved
3. Trend analysisIn review
4. CAPA and FSCA summaryDrafted
5. Conclusions and actionsDrafted

Data sources

Case recordsCAPA boardSignalsSales volumes

Reviewer comments

S. Reid: Add the lot 24-117 signal to section 3 with the threshold used.
Why it's harder now

Stricter rules, same old spreadsheets

GB post-market duties got stricter in 2025. Most small manufacturers still run them on spreadsheets and inboxes.

16 June 2025GB post-market surveillance rules in force
Part 4ANew duties added to the UK MDR 2002
2 to 5 peopleTypical RA/QA team carrying the extra load
TodayWith DeX
IntakeComplaints arrive by email, phone, portal and distributor, then get re-keyed.Every channel lands in one structured case.
ReportabilityOne or two experts decide. The reasoning is rarely written down the same way.AI proposes with cited criteria. A lead signs off.
DeadlinesReporting clocks live in calendars and inboxes.A timer on every case, escalating before breach.
Periodic reportsPMSRs stitched together by hand each cycle.Drafted from live data in MHRA's PMSR format.
GB, NI and EUSimilar but different duties, tracked in parallel.Separate rule sets applied to the same case.
Feedback loopFindings rarely reach risk, CAPA or design.Findings update the risk file and feed design change.
Team loadA small team can't absorb the extra volume.Agents do the reading, drafting and chasing.
What DeX does

Working records and reviewer responsibilities

A post-market surveillance hub built on DeX, set up around your PMS plan and running in your cloud.

DeX agents

Reading, drafting and chasing

Every report is read, coded and matched to device and lot. Drafts and reminders go out automatically.

Your RA and QA leads

Decide every report, risk and submission

Each decision is logged with its rationale.

Intake
Assess
Report
Correct
Trend
Periodic report
One complaint, start to finish

Follow one complaint from inbox to inspection-ready

Here's what happens to a single complaint. Hover over it to pause.

PMS-0418
    IntakeAny channel

    Complaint arrives

    Case PMS-0418Infusion pump IP-200 · Lot 24-117
    Example case
    Status
    With
    Report clock
      What's included

      Tools for post-market teams

      Capture
      Multi-channel intake

      Email, web form, distributor upload and API into one case.

      AI case structuring

      Pulls device, event, outcome and coding terms from free text.

      Decide
      Reportability support

      A proposed decision with reasoning, for human sign-off.

      Deadline clock

      A statutory timer per case. Escalates before breach.

      Report
      Report drafting

      Pre-filled vigilance and periodic reports in the current format.

      GB and EU rule sets

      Separate obligations, applied to the same case.

      Act
      CAPA and FSCA tracking

      Owners, effectiveness checks and customer notices.

      Trends and signals

      Dashboards by device, lot, failure mode and market.

      Govern
      Audit trail

      Role-based access, approvals and full change history.

      Knowledge base

      PMS plan, SOPs and past decisions, searchable.

      Who it's for

      Built for lean RA and QA teams

      Daily users
      Regulatory affairsQuality assuranceComplaints handlersVigilance leads
      Contributors
      Customer serviceField serviceDistributorsClinical affairs
      Decision makers
      Head of RA/QAPerson responsible for regulatory complianceCOO
      Reads the output
      UK Responsible PersonsMHRAApproved body auditors
      Best fit

      Companies selling devices into GB

      UK device and IVD makers, 20 to 500 staff
      Overseas manufacturers selling into GB
      UK Responsible Person service providers
      Importers and distributors
      Continue exploring

      Related MedTech workflows